Earnings Feed
Start Free
Viking Therapeutics, Inc.·4

Apr 14, 7:26 PM ET

FOEHR MATTHEW W 4

4 · Viking Therapeutics, Inc. · Filed Apr 14, 2025

Insider Transaction Report

Form 4
Period: 2025-04-11
Viking Therapeutics, Inc.VKTX
FOEHR MATTHEW W
Director
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.00001 per share

    2025-04-11$8.00/sh+20,786$166,288→ 132,036 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-04-11−20,786→ 0 total
    Exercise: $8.00From: 2016-05-26Exp: 2025-04-28→ Common Stock (20,786 underlying)

Documents

1 file
  • 4
    ownership.xmlPrimary

    4